Tau reduction prevents disease in a mouse model of Dravet syndrome
about
Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studiesSpreading depolarization in the brainstem mediates sudden cardiorespiratory arrest in mouse SUDEP modelsMechanisms of sudden unexplained death in epilepsyTau protein is essential for stress-induced brain pathologyPhosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice.Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia.Early rescue of interneuron disease trajectory in developmental epilepsies.Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.Pathway-driven discovery of epilepsy genes.Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model.Single-Gene Determinants of Epilepsy Comorbidity.One Mutation Deserves Another in the Quest for Antiepileptogenesis.Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.Atypical, non-standard functions of the microtubule associated Tau protein.Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice.Tau-based therapies in neurodegeneration: opportunities and challenges.Maintenance of the Innate Seizure Threshold by Cyclooxygenase-2 is Not Influenced by the Translational Silencer, T-cell Intracellular Antigen-1.Cognition and dementia in older patients with epilepsy.Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models.Tau in neurodegenerative disease.
P2860
Q27308052-C482520C-F8E6-4E4B-A24D-C57555BED9BBQ27325761-CCB1D386-FA1B-491A-9F6F-320E0ED2EE54Q28081176-2976AEAB-A35D-418D-B098-626BECFAC089Q30780692-0EE86A88-8931-4E98-85E1-85A908AA5559Q33709279-9F2F3C7A-4A70-4B98-9BDE-1C09B2D84324Q34796105-4BA622E4-6B3D-4B7E-8886-D4AA7D577DF3Q35594575-EE40835B-3998-4C65-9228-C435BD986DAAQ36410380-FB1AA8E2-2EBC-47F1-9D21-79670E4620DCQ36535757-DE41769D-F80F-409C-9446-E8B89F540EBBQ36759553-C6DC5BF4-02C2-43AB-82A3-9F5C7F5BF146Q36854796-E1127F1D-DF30-4628-852E-703B0CD5E026Q37292146-AFCAFBB2-B7E6-451D-AC7E-9A13314ED80EQ38622672-6883B87E-22D3-4FAA-9711-992AB15824C0Q41891534-BDBD65DB-9186-4F1A-83AC-96D9234FF363Q46533399-C0D86192-FCE6-4294-9C10-1EFA36A70914Q47145684-E69A3978-60B9-4B8E-AC4A-367FF9ACD312Q47667893-5BB0EF70-94A2-4D6B-8DE8-DD0216620BDBQ47689697-1DF19A42-F93E-4AA0-9557-A56AB482A093Q47862623-D112E4C4-CF39-4F8A-80FE-1657B19D832BQ51765675-3744F61C-5D2F-4DED-AB7F-845388E7A61BQ55385303-85C7EEB2-E09A-4437-8502-12B611BB8A89Q55421746-0F4E2C80-B855-413D-85E9-B880ED6C72BD
P2860
Tau reduction prevents disease in a mouse model of Dravet syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tau reduction prevents disease in a mouse model of Dravet syndrome
@ast
Tau reduction prevents disease in a mouse model of Dravet syndrome
@en
type
label
Tau reduction prevents disease in a mouse model of Dravet syndrome
@ast
Tau reduction prevents disease in a mouse model of Dravet syndrome
@en
prefLabel
Tau reduction prevents disease in a mouse model of Dravet syndrome
@ast
Tau reduction prevents disease in a mouse model of Dravet syndrome
@en
P2093
P2860
P356
P1433
P1476
Tau reduction prevents disease in a mouse model of Dravet syndrome
@en
P2093
Ania L Gheyara
Biljana Djukic
Kaitlyn Ho
Lennart Mucke
Mariel M Finucane
Pascal E Sanchez
Ravikumar Ponnusamy
Ryan J Craft
Weikun Guo
P2860
P304
P356
10.1002/ANA.24230
P577
2014-08-13T00:00:00Z